NCT03127423View on ClinicalTrials.gov

Comparison Between One-stage Hybrid Ablation and Thoracoscopic Surgical Ablation for Intractable Atrial Fibrillation

NACompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions

Persistent Atrial Fibrillation

Interventions

PROCEDURE

Hybrid ablation

This intervention includes totally thoracoscopic surgical ablation and percutaneous catheter ablation simultaneously.

PROCEDURE

Thoracoscopic surgical ablation

This intervention only includes totally thoracoscopic surgical ablation without percutaneous catheter ablation.

Trial Locations (1)

100037

China National Center for Cardiovascular Diseases, Beijing

All Listed Sponsors

lead

China National Center for Cardiovascular Diseases

OTHER_GOV

NCT03127423 - Comparison Between One-stage Hybrid Ablation and Thoracoscopic Surgical Ablation for Intractable Atrial Fibrillation | Biotech Hunter | Biotech Hunter